SpineThera
Plymouth
About SpineThera
SpineThera develops novel, sustained-release, injectable drugs to treat pain; offering patients and physicians alternatives that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs. It was founded in 2012 and is headquartered in Plymouth, Minnesota.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $30.5M
- Funding stage: M&A
- Last round: Grant (Apr 2022)
- Website: spinethera.com
- Phone: 612-508-4795
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/spinethera-34548 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.